Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I am expecting the basic no frills Cliff Flowers "Special" we have received for

stale reasoning for not providing Shareholders with updates due to your kind of likely (I agree) response from them, is really no longer an acceptable excuse. There are plenty of ways they can craft their "Open Letter" and still not compromise sensititives.

"I just do not think there is that much they can say right now with a possible appeal pending and negotiation filing"

PTSC is in the patent licensing business, that's our business model. As such, there will always be negotiations occuring, and probably Appeals from trials too. Litigation is the ordinary and customary aspect of any Patent Prosecution program, so, by extension, to use our standard method of conducting business as a canard for not communicating with Stockholders, or as a foil against Shareholders seeking updates, would mean they could always refuse to voluntarily inform us; except through required SEC filings and perhaps highly scripted SHAMs that very few shareholders can attend.

We need to change business as usual; it hasn't been working so well for Shareholders and the stock price.

Bring on the "Open Letter to Shareholders", and make it a genuine effort please.

Share
New Message
Please login to post a reply